<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39396052</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>12</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>Why were so few randomized trials of public health and social measures conducted during the COVID-19 pandemic? The Norwegian experience.</ArticleTitle><Pagination><StartPage>673</StartPage><MedlinePgn>673</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">673</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-024-08547-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Few randomized trials of public health and social measures were carried out during the COVID-19 pandemic. We report on the major barriers we faced when we tried to run such trials.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We reviewed all randomized trials proposed and initiated by the Centre for Epidemic Interventions Research in Norway during the COVID-19 pandemic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 18 proposed trials, 11 trials were not implemented. One of the key legal and ethical barriers to conducting the trials was the Norwegian Health Research Act, which demands informed consent from all participants who are exposed to an intervention. A lack of sufficient political support was also a challenge, as was unpredictability, due to shifting disease incidence and changing recommendations from the authorities.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Strengthening the evidence base for public health and social measures in pandemics will require political and public understanding and support and a legal framework that allows for the conduct of such trials.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fretheim</LastName><ForeName>Atle</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6268-7966</Identifier><AffiliationInfo><Affiliation>Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway. atle.fretheim@fhi.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elstrøm</LastName><ForeName>Petter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Julin</LastName><ForeName>Cathinka Halle</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gopinathan</LastName><ForeName>Unni</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elgersma</LastName><ForeName>Ingeborg Hess</ForeName><Initials>IH</Initials><AffiliationInfo><Affiliation>Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solberg</LastName><ForeName>Runar Barstad</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helleve</LastName><ForeName>Arnfinn</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Evaluation of Public Health Measures, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="Y">Randomized Controlled Trials as Topic</DescriptorName><QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName><QualifierName UI="Q000941" MajorTopicYN="N">ethics</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName><QualifierName UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007258" MajorTopicYN="N">Informed Consent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors are involved in the planning and conduct of randomized trials of public health and social measures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>13</Day><Hour>0</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>13</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>12</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39396052</ArticleId><ArticleId IdType="pmc">PMC11470701</ArticleId><ArticleId IdType="doi">10.1186/s13063-024-08547-2</ArticleId><ArticleId IdType="pii">10.1186/s13063-024-08547-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Enria D, Feng Z, Fretheim A, Ihekweazu C, Ottersen T, Schuchat A, Ungchusak K, Briand S, Haldane V, Lamichhane J, et al. Strengthening the evidence base for decisions on public health and social measures. Bull World Health Organ. 2021;99(9):610-610A. 10.2471/BLT.21.287054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381089</ArticleId><ArticleId IdType="pubmed">34475594</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasziou PP, Michie S, Fretheim A. Public health measures for covid-19. BMJ. 2021;375:n2729. 10.1136/bmj.n2729.</Citation><ArticleIdList><ArticleId IdType="pubmed">34789507</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasziou P, Sanders S, Byambasuren O, Thomas R, Hoffmann T, Greenwood H, van der Merwe M, Clark J. Clinical trials and their impact on policy during COVID-19: a review. Wellcome Open Res. 2024;9:20. 10.12688/wellcomeopenres.19305.1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10905118</ArticleId><ArticleId IdType="pubmed">38434720</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferson T, Dooley L, Ferroni E, Al-Ansary LA, van Driel ML, Bawazeer GA, Jones MA, Hoffmann TC, Clark J, Beller EM, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2023;1(1):CD006207. 10.1002/14651858.CD006207.pub6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9885521</ArticleId><ArticleId IdType="pubmed">36715243</ArticleId></ArticleIdList></Reference><Reference><Citation>Fretheim A, Elgersma IH, Kristiansen FA, Varmbo CR, Olsbo MKS, Glover IHS, Flato M. The effectiveness of free face mask distribution on use of face masks. A cluster randomised trial in Stovner District of Oslo, Norway. Int J Environ Res Public Health. 2021;18(17):8971. 10.3390/ijerph18178971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8430712</ArticleId><ArticleId IdType="pubmed">34501561</ArticleId></ArticleIdList></Reference><Reference><Citation>Elgersma IH, Fretheim A, Indseth T, Munch AT, Johannessen LB, Hansen CE. The evaluation of a social media campaign to increase COVID-19 testing in migrant groups: cluster randomized trial. J Med Internet Res. 2022;24(3):e34544. 10.2196/34544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8955230</ArticleId><ArticleId IdType="pubmed">35285811</ArticleId></ArticleIdList></Reference><Reference><Citation>Fretheim A, Elgersma IH, Helleve A, Elstrom P, Kacelnik O, Hemkens LG. Effect of wearing glasses on risk of infection with SARS-CoV-2 in the community: a randomized clinical trial. JAMA Netw Open. 2022;5(12):e2244495. 10.1001/jamanetworkopen.2022.44495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9716386</ArticleId><ArticleId IdType="pubmed">36454571</ArticleId></ArticleIdList></Reference><Reference><Citation>Solberg RB, Fretheim A, Elgersma IH, Fagernes M, Iversen BG, Hemkens LG, Rose CJ, Elstrom P. Personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: pragmatic randomised superiority trial. BMJ. 2024;386:e078918. 10.1136/bmj-2023-078918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11267995</ArticleId><ArticleId IdType="pubmed">39048132</ArticleId></ArticleIdList></Reference><Reference><Citation>Halle Julin C, Solberg R, Elgersma IH, Elstrøm P, Holst C, Helleve A, Gopinathan U, Fretheim A, Holøs SB. Study protocol: air purifiers in classrooms for infection control - a pilot study. 10.5281/zenodo.10526802. Accessed 18 Mar 2024.</Citation></Reference><Reference><Citation>Fagernes M, Eriksen-Volle HM, Holst C, Rose CJ, Solberg RB, Elstrøm P. Studieprotokoll: Evaluering av Nasjonalt verktøy for observasjon av smitteforebyggende tiltak i helsetjenesten (NOST) - en klynge-randomisert studie [Study protocol: Evaluation of a national tool for observing infection control measures in the health services - a cluster-randomized study]. https://www.fhi.no/contentassets/972079798c7f4f77b443cfc49658d6ad/studieprotokoll-evaluering-av-nost-v1.6.pdf. Accessed 18 Mar 2024.</Citation></Reference><Reference><Citation>Elstrøm P, Elgersma IH, Knardahl S, Fretheim A, Helleve A, Kacelnik O, Vestrheim D, Bruun T. The effect of working at home versus at the office on risk of transmission of SARS-CoV-2 and other respiratory agents. A randomized controlled trial (study protocol). https://www.fhi.no/contentassets/2c0bfe45f380425aabb296b0521f206e/the-effect-of-working-at-home-versus-at-the-office-study-protocol.pdf. Accessed 18 Mar 2024.</Citation></Reference><Reference><Citation>Solberg RB, Fretheim A, Elgersma IH, Fagernes M, Iversen BG, Hemkens LG, Rose CJ, Elstrøm P. The personal protective effect of wearing surgical face masks in public spaces on self-reported respiratory symptoms in adults: a pragmatic, randomised superiority trial. BMJ. 2024;386:e078918. 10.1136/bmj-2023-078918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11267995</ArticleId><ArticleId IdType="pubmed">39048132</ArticleId></ArticleIdList></Reference><Reference><Citation>Fretheim A, Flatø M, Steens A, Telle K, Stefanoff P, Helleve A, Bretthauer M, Bævre K, Rose CJ, Flottorp S et al. The School Opening in the Age of Pandemic (SOAP) Study: A Cluster-Randomised Re-Introduction of School Activities in Norway. Study protocol. https://jech.bmj.com/content/jech/74/12/1078/DC1/embed/inline-supplementary-material-1.pdf?download=true. Accessed 18 Mar 2024.</Citation></Reference><Reference><Citation>Fretheim A, Helleve A, Flatø M, Johansen TKB, Bretthauer M, Øverbø J, Feruglio SL, Kran AMB. Antigen rapid test screening to prevent SARS-CoV-2 transmission at mass gathering events. A protocol for a randomised trial. https://www.fhi.no/contentassets/82405514833e43b18bbd6f616865b385/antigen-rapid-test-screening-to-prevent-spread-of-covid-19-160421-draft-version.pdf. Accessed 18 Mar 2024.</Citation></Reference><Reference><Citation>International Ethical Guidelines for Health-related Research Involving Humans, 4th edn. Geneva: Council for International Organizations of Medical Sciences (CIOMS); 2016. https://cioms.ch/publications/product/international-ethical-guidelines-for-health-related-research-involving-humans. Accessed 10 Oct 2024.</Citation></Reference><Reference><Citation>Guidance Notes on the Instructions for Official Studies. Oslo: Norwegian Government Agency for Financial Management (DFØ); 2018. https://dfo.no/sites/default/files/fagomr%C3%A5der/Utredningsinstruksen/Guidance_Notes_on_the_Instructions_for_Official_Studies.pdf. Accessed 10 Oct 2024.</Citation></Reference><Reference><Citation>Helsingen LM, Loberg M, Refsum E, Gjostein DK, Wieszczy P, Olsvik O, Juul FE, Barua I, Jodal HC, Herfindal M, et al. Covid-19 transmission in fitness centers in Norway - a randomized trial. BMC Public Health. 2021;21(1):2103. 10.1186/s12889-021-12073-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8595959</ArticleId><ArticleId IdType="pubmed">34789188</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemming K, Haines TP, Chilton PJ, Girling AJ, Lilford RJ. The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting. BMJ. 2015;350:h391. 10.1136/bmj.h391.</Citation><ArticleIdList><ArticleId IdType="pubmed">25662947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy-Shaffer L, Lipsitch M. Statistical properties of stepped wedge cluster-randomized trials in infectious disease outbreaks. Am J Epidemiol. 2020;189(11):1324–32. 10.1093/aje/kwaa141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7604531</ArticleId><ArticleId IdType="pubmed">32648891</ArticleId></ArticleIdList></Reference><Reference><Citation>Abaluck J, Kwong LH, Styczynski A, Haque A, Kabir MA, Bates-Jefferys E, Crawford E, Benjamin-Chung J, Raihan S, Rahman S, et al. Impact of community masking on COVID-19: a cluster-randomized trial in Bangladesh. Science. 2022;375(6577):eabi9069. 10.1126/science.abi9069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9036942</ArticleId><ArticleId IdType="pubmed">34855513</ArticleId></ArticleIdList></Reference><Reference><Citation>ISRCTN63437172. Testing whether air filters can prevent winter respiratory infections (including COVID-19) in care homes (trial registration). 10.1186/ISRCTN63437172. Acessed 7 May 2024.</Citation></Reference><Reference><Citation>ISRCTN46750688. Classroom air cleaning technology study (trial registration). 10.1186/ISRCTN46750688. Accessed 7 May 2024.</Citation></Reference><Reference><Citation>Kieny MP, Salama P. WHO R&amp;D Blueprint: a global coordination mechanism for R&amp;D preparedness. Lancet. 2017;389(10088):2469–70. 10.1016/S0140-6736(17)31635-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28656895</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean NE, Gsell PS, Brookmeyer R, Crawford FW, Donnelly CA, Ellenberg SS, Fleming TR, Halloran ME, Horby P, Jaki T, et al. Creating a framework for conducting randomized clinical trials during disease outbreaks. N Engl J Med. 2020;382(14):1366–9. 10.1056/NEJMsb1905390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7490833</ArticleId><ArticleId IdType="pubmed">32242365</ArticleId></ArticleIdList></Reference><Reference><Citation>Report of the WHO global technical consultation on public health and social measures during health emergencies: online meeting, 31 August to 2 September 2021. In. Geneva: World Health Organization; 2022. https://www.who.int/publications/i/item/9789240043213. Accessed 10 Oct 2024.</Citation></Reference><Reference><Citation>The Pandemic EVIDENCE Collaboration: Kellogg College, University of Oxford; 2024. https://www.kellogg.ox.ac.uk/the-pandemic-evidence-collaboration. Accessed 18 Mar 2024.</Citation></Reference><Reference><Citation>Taljaard M, Weijer C, Grimshaw JM, Eccles MP. Ottawa ethics of cluster randomised trials consensus G: the Ottawa statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees. BMJ. 2013;346:f2838. 10.1136/bmj.f2838.</Citation><ArticleIdList><ArticleId IdType="pubmed">23661113</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKay D, Chakrabarti A. Government Policy Experiments and Informed Consent. Public Health Eth-Uk. 2019;12(2):188–201. 10.1093/phe/phy015.</Citation></Reference><Reference><Citation>Weijer C, Taljaard M. Ethical Challenges Associated with Pragmatic and Cluster RCTs. N Engl J Med. 2024;391(11):969–71. 10.1056/NEJMp2403550.</Citation><ArticleIdList><ArticleId IdType="pubmed">39282923</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>